BamSEC and AlphaSense Join Forces
Learn More

Enveric Biosciences Inc.

NASDAQ: ENVB    
Share price (12/20/24): $0.33    
Market cap (12/20/24): $3.232 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 10-Q 30 pages Certain Information Identified by “[***]” Has Been Excluded From the Exhibit Because It Is Both Not Material and Is the Type of Information That the Registrant Treats as Private or Confidential. Exclusive License Agreement Pharmaceutical and Otc Cannabinoid Compounds for Treatment of Radiation Dermatitis
12/34/56
EX-10.1
from 8-K 13 pages Enveric Biosciences, Inc. Common Stock Purchase Agreement
12/34/56
EX-10.1
from 8-K 13 pages Enveric Biosciences. Inc. Common Stock Purchase Agreement
12/34/56
EX-10.1
from 8-K 10 pages [Name and Address of Warrant Holder] Re: Reprice and Reload Offer of Common Stock Purchase Warrants to Whom It May Concern
12/34/56
EX-10.44
from S-1 15 pages Registration Rights Agreement
12/34/56
EX-10.43
from S-1 37 pages Purchase Agreement
12/34/56
EX-10.2
from 8-K 15 pages Registration Rights Agreement
12/34/56
EX-10.1
from 8-K 37 pages Purchase Agreement
12/34/56
EX-10.1
from 8-K 20 pages Enveric Biosciences, Inc. 2020 Long-Term Incentive Plan, as Amended
12/34/56
EX-10.2
from 10-Q 3 pages Certain Information Identified by “[***]” Has Been Excluded From the Exhibit Because It Is Both Not Material and Is the Type of Information That the Registrant Treats as Private or Confidential. Termination of Prior Agreements and Mutual Release
12/34/56
EX-10.1
from 8-K 10 pages Employment Agreement
12/34/56
EX-10.4
from 8-K 2 pages Holder of Warrants to Purchase Common Stock Issued on February 15, 2022 Re: Amendment to Existing Warrants Dear Holder: Reference Is Hereby Made to the Concurrent Private Placement and Registered Direct Offering on or About the Date Hereof (The “Offering”) by Enveric Biosciences, Inc. (The “Company”) of Its Securities (Collectively, the “Securities”)
12/34/56
EX-10.3
from 8-K 27 pages Registration Rights Agreement
12/34/56
EX-10.2
from 8-K 42 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 40 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 3 pages First Amendment to the Enveric Biosciences, Inc. 2020 Long-Term Incentive Plan
12/34/56
EX-10.4
from 8-K 19 pages Acanna Therapeutics, Inc. Warrant to Purchase Common Stock
12/34/56
EX-10.3
from 8-K 27 pages Registration Rights Agreement
12/34/56
EX-10.2
from 8-K 17 pages Certificate of Designations, Preferences and Rights of the Series a Convertible Preferred Stock of Acanna Therapeutics, Inc
12/34/56
EX-10.1
from 8-K 32 pages Securities Purchase Agreement
12/34/56